all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases retinopathy of prematurity incidence
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“The incidence of Type 1 ROP was lower in the VA group.”
Quoted verbatim from EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS.. - Study
- RCT
- Duration
- 4 weeks
- Dose
- 1,500 IU/day oral vitamin A added to enteral feeds for 28 days or until discharge, versus soybean oil placebo
- Population
- Extremely preterm infants (<28 weeks, <96 hours old) in three neonatal intensive care units in China; all infants also received the standard intravenous multivitamin within parenteral nutrition
EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS.2020PMID:30964778Permalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against Retinopathy of prematurity incidence
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5JSSWJE3538PEF53XEGB5MH